<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To examine whether the inflammatory phenotype found in <z:mp ids='MP_0001261'>obese</z:mp> and diabetic individuals is preserved in isolated, cultured myocytes and to assess the effectiveness of pharmacological <z:chebi fb="47" ids="16027,28971">AMP</z:chebi>-activated protein kinase (AMPK) activation upon the attenuation of <z:mp ids='MP_0001845'>inflammation</z:mp> in these myocytes </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: Muscle precursor cells were isolated from four age-matched subject groups: 1) nonobese, <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerant; 2) <z:mp ids='MP_0001261'>obese</z:mp>, <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerant; 3) <z:mp ids='MP_0001261'>obese</z:mp>, impaired <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerant; and 4) <z:mp ids='MP_0001261'>obese</z:mp>, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (T2D) </plain></SENT>
<SENT sid="2" pm="."><plain>The level of <z:mp ids='MP_0001845'>inflammation</z:mp> (nuclear factor-κB [NF-κB] signaling) and effect of pharmacological AMPK activation was assessed by Western blots, enzyme-linked immunosorbent assay, and radioactive assays (n = 5 for each subject group) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: NF-κB-p65 DNA binding activity was significantly elevated in myocytes from <z:mp ids='MP_0001261'>obese</z:mp> T2D patients compared with nonobese control subjects </plain></SENT>
<SENT sid="4" pm="."><plain>This correlated to a significant increase in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-α concentration in cell culture media </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, insulin-stimulated <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake was completely suppressed in myocytes from <z:mp ids='MP_0001261'>obese</z:mp> impaired <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerant and T2D subjects </plain></SENT>
<SENT sid="6" pm="."><plain>It is interesting that activation of AMPK by A769662 attenuated NF-κB-p65 DNA binding activity in <z:mp ids='MP_0001261'>obese</z:mp> T2D cells to levels measured in nonobese myocytes; however, this had no effect on insulin sensitivity of the cells </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: This work provides solid evidence that differentiated human muscle precursor cells maintain in vivo phenotypes of <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and that <z:hpo ids='HP_0001513'>obesity</z:hpo> alone may not be sufficient to establish <z:mp ids='MP_0001845'>inflammation</z:mp> in these cells </plain></SENT>
<SENT sid="8" pm="."><plain>It is important that we demonstrate an anti-inflammatory role for AMPK in these human cells </plain></SENT>
<SENT sid="9" pm="."><plain>Despite attenuation of NF-κB activity by AMPK, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in <z:mp ids='MP_0001261'>obese</z:mp> T2D cells remained, suggesting factors in addition to <z:mp ids='MP_0001845'>inflammation</z:mp> may contribute to the <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> phenotype in muscle cells </plain></SENT>
</text></document>